Listed

Lisata Therapeutics, Inc.

LSTANasdaqCIK 320017HealthcareFiscal year ends Dec 31

Reports and events: 393 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Lisata Therapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2024-02-2916:12 ET10-KAnnual reportPeriod 2023-12-310000320017-24-000007
2024-02-2916:09 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000320017-24-000006
2023-11-0216:11 ET10-QQuarterly reportPeriod 2023-09-300000320017-23-000063
2023-11-0216:10 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000320017-23-000062
2023-08-1416:10 ET10-QQuarterly reportPeriod 2023-06-300000320017-23-000055
2023-08-1416:08 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000320017-23-000054
2023-07-1116:01 ET8-K5.02 Departure or appointment of officers or directors0000320017-23-000037
2023-06-1417:05 ET8-K5.07 Shareholder vote results0000320017-23-000031
2023-05-0916:09 ET10-QQuarterly reportPeriod 2023-03-310000320017-23-000028
2023-05-0916:08 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000320017-23-000027
2023-05-0116:02 ETDEF 14AProxy statementPeriod 2023-05-010000320017-23-000022
2023-05-0116:01 ET8-K5.02 Departure or appointment of officers or directors0000320017-23-000021
2023-03-3016:09 ET10-KAnnual reportPeriod 2022-12-310000320017-23-000011
2023-03-3016:07 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000320017-23-000010
2023-02-0616:02 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0000320017-23-000003
2022-11-1016:12 ET10-QQuarterly reportPeriod 2022-09-300000320017-22-000102
2022-11-1016:10 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000320017-22-000101
2022-10-1416:01 ET8-K/A9.01 Financial statements and exhibits0001140361-22-037226
2022-10-0416:42 ET8-K/A8.01 Other events; 9.01 Financial statements and exhibits0001140361-22-036093
2022-09-2916:01 ET8-K8.01 Other events0000320017-22-000094
2022-09-2216:02 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0000320017-22-000085
2022-09-1509:16 ET8-K2.01 Completion of an acquisition or disposition; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001140361-22-033411
2022-09-1417:01 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0000320017-22-000079
2022-08-1912:33 ET8-K3.01 Delisting notice0000320017-22-000071
2022-08-0516:01 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000320017-22-000061
2022-08-0416:44 ET10-QQuarterly reportPeriod 2022-06-300000320017-22-000057
2022-05-2316:08 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000320017-22-000046
2022-05-0516:09 ET10-QQuarterly reportPeriod 2022-03-310000320017-22-000042
2022-05-0516:07 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000320017-22-000041
2022-04-2707:05 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0000320017-22-000031
2022-04-2116:04 ET10-K/AAnnual report, amendedPeriod 2021-12-310000320017-22-000025
2022-03-2216:10 ET10-KAnnual reportPeriod 2021-12-310000320017-22-000016
2022-03-2216:09 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000320017-22-000015
2022-02-2516:15 ET8-K5.02 Departure or appointment of officers or directors0000320017-22-000008
2022-02-1816:47 ET8-K3.01 Delisting notice0000320017-22-000005
2021-11-0416:12 ET10-QQuarterly reportPeriod 2021-09-300000320017-21-000108
2021-11-0416:09 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000320017-21-000107
2021-08-0516:14 ET10-QQuarterly reportPeriod 2021-06-300000320017-21-000100
2021-08-0516:09 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000320017-21-000099
2021-06-1616:20 ET8-K5.07 Shareholder vote results0000320017-21-000079
2021-06-0416:44 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0000320017-21-000075
2021-05-0616:08 ET10-QQuarterly reportPeriod 2021-03-310000320017-21-000067
2021-05-0616:06 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000320017-21-000066
2021-04-2816:03 ETDEF 14AProxy statementPeriod 2021-04-280000320017-21-000056
2021-03-1917:23 ET8-K5.01 Change in control; 9.01 Financial statements and exhibits0000320017-21-000046
2021-02-2516:08 ET10-KAnnual reportPeriod 2020-12-310000320017-21-000043
2021-02-2516:07 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000320017-21-000042
2021-02-1616:51 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0000320017-21-000032
2021-01-2907:58 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000320017-21-000009
2021-01-2516:01 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0000320017-21-000006

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 19:21 ET. Listed shows no prices and gives no investment advice.